CS228106B2 - Production of novel derivatives of 3-/4-phenoxymethylpiperidino/-propanol - Google Patents

Production of novel derivatives of 3-/4-phenoxymethylpiperidino/-propanol Download PDF

Info

Publication number
CS228106B2
CS228106B2 CS777291A CS729177A CS228106B2 CS 228106 B2 CS228106 B2 CS 228106B2 CS 777291 A CS777291 A CS 777291A CS 729177 A CS729177 A CS 729177A CS 228106 B2 CS228106 B2 CS 228106B2
Authority
CS
Czechoslovakia
Prior art keywords
hydroxy
propoxy
group
alkyl
hydrogen
Prior art date
Application number
CS777291A
Other languages
Czech (cs)
English (en)
Inventor
Wolfgang Dr Kampe
Walter Gunar Dr Friebe
Fritz Dr Wiedemann
Gisbert Dr Sponer
Wolfgang Dr Bartsch
Karel Dietmann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762651574 external-priority patent/DE2651574A1/de
Priority claimed from DE19772737630 external-priority patent/DE2737630A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Priority to CS785461A priority Critical patent/CS228110B2/cs
Priority to CS785459A priority patent/CS228108B2/cs
Priority to CS785460A priority patent/CS228109B2/cs
Publication of CS228106B2 publication Critical patent/CS228106B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS777291A 1976-11-12 1977-11-08 Production of novel derivatives of 3-/4-phenoxymethylpiperidino/-propanol CS228106B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CS785461A CS228110B2 (en) 1976-11-12 1978-08-21 Production of novel derivatives of 3-/4-phenoxymethylpi
CS785459A CS228108B2 (cs) 1977-08-20 1978-08-21 Způsob výroby nových derivátů 3-(4-fenoxymethylpiperidino)propanolu
CS785460A CS228109B2 (cs) 1977-08-20 1978-08-21 Způsob výroby nových derivátů 3-(4-fenoxymethylpiperidino)propanolu

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19762651574 DE2651574A1 (de) 1976-11-12 1976-11-12 Ein neues aminopropanol-derivat und verfahren zu dessen herstellung
DE19772737630 DE2737630A1 (de) 1977-08-20 1977-08-20 Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
CS228106B2 true CS228106B2 (en) 1984-05-14

Family

ID=25771134

Family Applications (1)

Application Number Title Priority Date Filing Date
CS777291A CS228106B2 (en) 1976-11-12 1977-11-08 Production of novel derivatives of 3-/4-phenoxymethylpiperidino/-propanol

Country Status (23)

Country Link
US (1) US4146630A (fi)
JP (1) JPS5363385A (fi)
AR (3) AR218643A1 (fi)
AT (1) AT361476B (fi)
AU (1) AU510284B2 (fi)
CA (1) CA1086740A (fi)
CH (3) CH636099A5 (fi)
CS (1) CS228106B2 (fi)
DD (1) DD133801A5 (fi)
DK (1) DK500677A (fi)
ES (2) ES472747A1 (fi)
FI (1) FI62077C (fi)
FR (1) FR2370744A1 (fi)
GB (1) GB1541547A (fi)
HU (1) HU177410B (fi)
IL (1) IL53323A (fi)
IT (1) IT1087490B (fi)
LU (1) LU78498A1 (fi)
NL (1) NL7712220A (fi)
PL (2) PL112683B1 (fi)
SE (1) SE7712720L (fi)
SU (2) SU826955A3 (fi)
YU (3) YU266477A (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314943A (en) * 1977-07-13 1982-02-09 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
US4495352A (en) * 1979-02-13 1985-01-22 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
DE2905876A1 (de) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue piperidinopropylderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2922084A1 (de) * 1979-05-31 1980-12-11 Boehringer Mannheim Gmbh Neue aminopropanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3200304A1 (de) * 1981-01-16 1982-08-26 Sandoz-Patent-GmbH, 7850 Lörrach 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
AU575153B2 (en) * 1984-04-09 1988-07-21 Du Pont Merck Pharmaceutical Company, The Pharmaceutical compositions and method for treatment for prophylaxis of cardiac disorders
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
US5614523A (en) * 1995-01-17 1997-03-25 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5627196A (en) * 1995-01-17 1997-05-06 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5789402A (en) * 1995-01-17 1998-08-04 Eli Lilly Company Compounds having effects on serotonin-related systems
US5741789A (en) * 1995-01-17 1998-04-21 Eli Lilly And Company Compounds having effects on serotonin-related systems
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
WO2010059390A1 (en) 2008-10-30 2010-05-27 Janssen Pharmaceutica Nv Modulators of serotonin receptor
US8642583B2 (en) * 2008-10-30 2014-02-04 Janssen Pharmaceutica Nv Serotonin receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB925429A (en) * 1960-04-01 1963-05-08 Irwin Neisler & Co Indole derivatives
US3699123A (en) * 1970-03-24 1972-10-17 Sandoz Ltd 4-(3-amino-2-hydroxy-propoxy) indole derivatives
BE794333A (fr) * 1972-01-20 1973-07-19 Wyeth John & Brother Ltd Composes heterocycliques azotes therapeutiques
JPS517672B2 (fi) * 1972-04-13 1976-03-10
JPS6024100B2 (ja) * 1975-02-11 1985-06-11 ベーリンガー・マンハイム・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング アミノプロパノ−ル−誘導体の製法
DE2549568C3 (de) * 1975-11-05 1981-10-29 Bayer Ag, 5090 Leverkusen 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel

Also Published As

Publication number Publication date
HU177410B (en) 1981-10-28
JPS6341910B2 (fi) 1988-08-19
ATA808277A (de) 1980-08-15
ES472746A1 (es) 1979-02-16
IL53323A0 (en) 1978-01-31
SE7712720L (sv) 1978-05-13
CA1086740A (en) 1980-09-30
NL7712220A (nl) 1978-05-17
AR221868A1 (es) 1981-03-31
SU826955A3 (ru) 1981-04-30
IL53323A (en) 1981-12-31
DD133801A5 (de) 1979-01-24
FR2370744B1 (fi) 1981-06-12
AT361476B (de) 1981-03-10
US4146630A (en) 1979-03-27
AU510284B2 (en) 1980-06-19
PL110782B1 (en) 1980-07-31
YU266477A (en) 1984-02-29
AR218643A1 (es) 1980-06-30
CH643554A5 (de) 1984-06-15
YU128883A (en) 1984-04-30
CH636099A5 (de) 1983-05-13
IT1087490B (it) 1985-06-04
FI62077C (fi) 1982-11-10
ES472747A1 (es) 1979-02-16
SU890975A3 (ru) 1981-12-15
DK500677A (da) 1978-05-13
AR221081A1 (es) 1980-12-30
GB1541547A (en) 1979-03-07
CH639086A5 (de) 1983-10-31
AU3046677A (en) 1979-05-17
PL112683B1 (en) 1980-10-31
FI773346A (fi) 1978-05-13
YU128983A (en) 1984-04-30
JPS5363385A (en) 1978-06-06
FI62077B (fi) 1982-07-30
LU78498A1 (fi) 1979-02-02
PL201997A1 (pl) 1979-03-12
FR2370744A1 (fr) 1978-06-09

Similar Documents

Publication Publication Date Title
CS228106B2 (en) Production of novel derivatives of 3-/4-phenoxymethylpiperidino/-propanol
US4243807A (en) 4-Phenoxymethyl-piperidines
US5106862A (en) Derivatives of benzimidazoles active as anti-ulcer agents
US4259338A (en) Benzofuranyl-tetrahydropyridines and -piperidines, their acid addition salts and antidepressant preparations thereof
US5403816A (en) Picolinic acid derivative and herbicidal composition
EP0144986B1 (en) Indole-3-carboxamide derivatives
US5006534A (en) Substituted ethers, thioethers and amines for use as lipoxygenase inhibitors
US4404384A (en) O-[3-(4-Substituted-piperazin-1-yl)-2-hydroxypropyl]-hydroxylamines
CZ285369B6 (cs) Derivát 3-indolylpiperidinu, způsob jeho přípravy, jeho použití pro přípravu farmaceutického prostředku a farmaceutický prostředek, který ho obsahuje
NO125911B (fi)
HU186024B (en) Process for preparing new carboxylic acid amides
SU1041033A3 (ru) Способ получени производных аминопропанола или их солей
IL33507A (en) 4-halophenyl-1-phenoxypropyl-3,6-dihydro-1(2h)-pyridine derivatives,their preparation and pharmaceutical compositions containing them
DE2737630C2 (fi)
US4585869A (en) 3-aminoindazole derivatives
NO124724B (fi)
US4442102A (en) 1,5-Diphenylpyrazolin-3-one compounds, process and intermediates for preparation thereof and pharmaceutical compositions containing same
NO164899B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
JPS5845423B2 (ja) 新規アミノプロパノ−ル・誘導体の製法
US4537975A (en) 1-Phenylindazol-3-one compounds
GB2056435A (en) Novel Tetrahydropyridine and Piperidine Substituted Benzofuranes and Related Compounds
NO121212B (fi)
US5112978A (en) Process for preparing alpha (alkyl phenyl)-4(hydroxy-diphenylmethyl)-1-piperidinyl butanol
US4767767A (en) 2-pyrrolidinylethyl-2-(7-trifluoromethyl-4-quinolyl-aminobenzoate having analgesic, antipyretic and anti-inflammatory activities
JPS6212757A (ja) 桂皮酸アミド誘導体